Floatz logo

ub-312

Parkinsonism

United Neuroscience Ltd.Phase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Parkinsonism cohort.

Asset / SponsorPhaseRating
Zoledronate
California Pacific Medical Center Research Institute
Phase 4BB
Meta-Iodobenzylguanidine
Mayo Clinic
Phase 4BB
IOFLUPANE
Mayo Clinic
Phase 4BB
Zonisamide
The Cooper Health System
Phase 4B
Varenicline Tartrate
Corporal Michael J. Crescenz VA Medical Center
Phase 4B
Droxidopa
The Cooper Health System
Phase 4B
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells
Indonesia University
N/AD
Ramelteon
Northwestern University
N/AD

Same molecule, other indications

ub-312 is also rated in:

multiple system atrophyDormant
CC
Indicative ·
46 / 100
View asset →
Parkinson diseaseDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →